Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.
By M. Sulkowski, D. Thomas, R. Chaisson, R. Moore. Journal of the American Medical Association (JAMA), 2000
1,014 citations recorded by the source corpus.
Subfields: Hepatology, Infectious Diseases, Pharmacology
View Paper: https://www.semanticscholar.org/paper/4fd73d0e3dae2cd1728574347959e803c533eb81
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- R. Weber
- C. Sabin
- A. Phillips
- C. Graham
- P. Reiss
- N. Friis‐Møller
- L. Baden
- W. El-Sadr
Citations in the corpus
- Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. (2001, background): “496 • CID 2001:32 (1 February) • HIV/AIDS HCV or HBV infection tolerated their medications without serious adverse effects as evidenced by liver function tests [25].”
- Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. (2002, background): “Because the risk of liver toxicity may be mildly increased in coinfected patients treated with HAART, universal testing of HIV-infected patients before initiation of antiviral therapy for HIV might be indicated [15].”
- Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. (2004, background): “HCV infection Estimated duration of infection, median (range), y 16 (2-30) 17 (3-33) .”
- ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. (2021, background): “Antiretroviral hepatotoxicity seems to be more common in human immunodeficiency virus patients with HCV or HBV coinfection (160).”
- Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. (2006, background): “0 CD4 cell count, median (range), /μL Nadir 19 (0-530) 102 (0-761) 108 (0-1150) Before death 40 (0-957) 196 (6-1200) 266 (0-1878) Previous AIDS before death, % 100.”
- Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. (2001, background): “Other studies have found an increase in the levels of transaminase or frank liver decompensation in patients treated with HAART [34–36].”